Laparoscopic supracervical hysterectomy with concomitant bilateral salpingectomy-why not?

Anticancer Research

Volumn 33, Issue 6, 2013, Pages 2771-2774

  Berlit, Sebastian ^a   Tuschy, Benjamin ^a   Kehl, Sven ^a   Brade, Joachim ^b   Sütterlin, Marc ^a   Hornemann, Amadeus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Laparoscopic supracervical hysterectomy; Laparoscopy; LASH; Prophylactic salpingectomy; Surgical outcome

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HOSPITALIZATION; HUMAN; HYSTERECTOMY; LAPAROSCOPIC SUPRACERVICAL HYSTERECTOMY; LAPAROSCOPIC SURGERY; LENGTH OF STAY; OPERATION DURATION; OPERATIVE BLOOD LOSS; PATIENT SAFETY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SALPINGECTOMY; SURGEON; TREATMENT OUTCOME; LAPAROSCOPY; LASH; MIDDLE AGED; OVARY TUMOR; POSTOPERATIVE COMPLICATION; PROPHYLACTIC SALPINGECTOMY; RETROSPECTIVE STUDY; SURGICAL OUTCOME; UTERINE TUBE;

LAPAROSCOPIC SUPRACERVICAL HYSTERECTOMY; LAPAROSCOPY; LASH; PROPHYLACTIC SALPINGECTOMY; SURGICAL OUTCOME;

FALLOPIAN TUBES; FEMALE; HUMANS; HYSTERECTOMY; LAPAROSCOPY; MIDDLE AGED; OVARIAN NEOPLASMS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; SALPINGECTOMY; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84881339919     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Dietl J, Wischhusen J and Hausler SF: The post-reproductive Fallopian tube: Better removed? Hum Reprod 26(11): 2918-2924, 2011.
2. Ghezzi F, Cromi A, Siesto G, Bergamini V, Zefiro F and Bolis P: Infectious morbidity after total laparoscopic hysterectomy: Does concomitant salpingectomy make a difference? Br J Obstet Gynaecol 116(4): 589-593, 2009.
3. Morse AN, Schroeder CB, Magrina JF, Webb MJ, Wollan PC and Yawn BP: The risk of hydrosalpinx formation and adnexectomy following tubal ligation and subsequent hysterectomy: A historical cohort study. Am J Obstet Gynecol 194(5): 1273-1276, 2006.
4. Singla A: An unusual case of torsion hydrosalpinx after hysterectomy: A case report. Aust N Z J Obstet Gynaecol 47(3): 256-257, 2007.
5. Timor-Tritsch IE, Monteagudo A and Tsymbal T: Threedimensional ultrasound inversion rendering technique facilitates the diagnosis of hydrosalpinx. J Clin Ultrasound 38(7): 372-376, 2010.
6. Rezvani M and Shaaban AM: Fallopian tube disease in the nonpregnant patient. Radiographics 31(2): 527-548, 2011.
7. Piacenza JM and Salsano F: Post-hysterectomy fallopian tube prolapse. Eur J Obstet Gynecol Reprod Biol 98(2): 253-255, 2001.
8. Cattanach J: Oestrogen deficiency after tubal ligation. Lancet 1(8433): 847-849, 1985.
9. Chan CC, Ng EH, Li CF and Ho PC: Impaired ovarian blood flow and reduced antral follicle count following laparoscopic salpingectomy for ectopic pregnancy. Hum Reprod 18(10): 2175-2180, 2003.
10. Dar P, Sachs GS, Strassburger D, Bukovsky I and Arieli S: Ovarian function before and after salpingectomy in artificial reproductive technology patients. Hum Reprod 15(1): 142-144, 2000.
11. Strandell A, Lindhard A, Waldenstrom U and Thorburn J: Prophylactic salpingectomy does not impair the ovarian response in IVF treatment. Hum Reprod 16(6): 1135-1139, 2001.
12. Sezik M, Ozkaya O, Demir F, Sezik HT an: Kaya H. Total salpingectomy during abdominal hysterectomy: Effects on ovarian reserve and ovarian stromal blood flow. J Obstet Gynaecol Res 33(6): 863-869, 2007.
13. Piek JM, van Diest PJ, Zweemer RP, Jansen JW, Poort-Keesom RJ, Menko FH, Gille JJ, Jongsma AP, Pals G, Kenemans P and Verheijen RH: Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 195(4): 451-456, 2001.
14. Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, Callahan MJ, Garner EO, Gordon RW, Birch C, Berkowitz RS, Muto MG and Crum CP: Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol 31(2): 161-169, 2007.
15. Marquez RT, Baggerly KA, Patterson AP, Liu J, Broaddus R, Frumovitz M, Atkinson EN, Smith DI, Hartmann L, Fishman D, Berchuck A, Whitaker R, Gershenson DM, Mills GB, Bast RC Jr. and Lu KH: Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res 11(17): 6116-6126, 2005.
16. Tone AA, Begley H, Sharma M, Murphy J, Rosen B, Brown TJ, Shaw PA: Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma. Clin Cancer Res 14(13): 4067-4078, 2008.
17. Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, Garber JE, Cramer DW, Crum CP: The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 30(2): 230-236, 2006.
18. Rebbeck TR, Kauff ND and Domchek SM: Meta-Analysis of risk reduction estimates associated with risk-reducing salpingooophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101(2): 80-87, 2009.
19. Leblanc E, Narducci F, Farre I, Peyrat JP, Taieb S, Adenis C and Vennin P: Radical fimbriectomy: a reasonable temporary riskreducing surgery for selected women with a germ line mutation of BRCA1 or -2 genes? Rationale and preliminary development. Gynecol Oncol 121(3): 472-476, 2011.
20. Greene MH and Mai PL: What have we learned from riskreducing salpingo-oophorectomy? J Natl Cancer Inst 101(2): 70-71, 2009.
21. Kwon JS, Tinker A, Pansegrau G, McAlpine J, Housty M, McCullum M and Gilks CB: Prophylactic Salpingectomy and Delayed Oophorectomy as an Alternative for BRCA Mutation Carriers. Obstet Gynecol 121(1): 14-24, 2013.